Andrew Levin
Listed on 8 Form D filings across 7+ issuers
· Director
Associated issuers
- Climb Bio, Inc. CIK 1768446 · MA
- Slate Medicines, Inc. CIK 2117806 · MA
- Solstice Oncology, Inc. CIK 2116600 · MA
- Lonestar Medicines, Inc. CIK 2111460 · MA
- Imbria Pharmaceuticals, Inc. CIK 1745672 · MA
- Superluminal Medicines, Inc. CIK 1989478 · MA
- Pahr Therapeutics, Inc. CIK 2077159 · MA
Filings (8)
-
Climb Bio, Inc.D · 2026-05-04 · MA · Biotechnology$110.1Mview →
-
Slate Medicines, Inc.D · 2026-03-11 · MA · Pharmaceuticals$130Mview →
-
Solstice Oncology, Inc.D · 2026-03-09 · MA · Biotechnology$298.4Mview →
-
Lonestar Medicines, Inc.D · 2026-02-23 · MA · Biotechnology$45Mview →
-
Imbria Pharmaceuticals, Inc.D · 2025-12-16 · MA · Biotechnology$144.2Mview →
-
Superluminal Medicines, Inc.D · 2025-08-26 · MA · Biotechnology$5Mview →
-
Pahr Therapeutics, Inc.D · 2025-07-18 · MA · Biotechnology$14Mview →
-
Imbria Pharmaceuticals, Inc.D · 2025-04-01 · MA · Biotechnology$124.2Mview →